 |
인쇄하기
취소
|
Plavix patent war getting fiercer
A paten war, ignited by Korean pharmaceutical firms, is getting fiercer as Sanofi-Aventis Korea unveiled its plan to defend its original Plavix patent with all possible legal means on January 15.
Experts cite growing demand for Plavix (clopidogrel bisulfate) and intensifying competition among drug manufacturers as the main reasons behind the escalating dispute.
The local patent court will...
Experts cite growing demand for Plavix (clopidogrel bisulfate) and intensifying competition among drug manufacturers as the main reasons behind the escalating dispute.
The local patent court will...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.